Genpact LTD — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Genpact LTD filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $601.53M | Feb 27, 2015 |
| FY2014 | Sep 30, 2014 | $588.11M | Feb 27, 2015 |
| FY2014 | Jun 30, 2014 | $561.61M | Feb 27, 2015 |
| FY2014 | Mar 31, 2014 | $528.19M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $558.46M | Feb 27, 2015 |
| FY2014 | Sep 30, 2013 | $534.89M | Feb 27, 2015 |
| FY2014 | Jun 30, 2013 | $534.80M | Feb 27, 2015 |
| FY2014 | Mar 31, 2013 | $503.85M | Feb 27, 2015 |
| FY2013 | Dec 31, 2012 | $507.70M | Feb 28, 2014 |
| FY2013 | Sep 30, 2012 | $491.16M | Feb 28, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.08B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.77B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $4.48B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $4.37B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $4.02B | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $950.57M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $935.52M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $900.09M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $923.19M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $940.74M | Mar 1, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.69B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.57B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.54B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.43B | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $336.92M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $329.69M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $306.20M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $318.42M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $310.09M | Mar 1, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $552.49M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $513.67M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $631.26M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $353.40M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $369.45M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $308.28M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $82.20M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $88.12M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $73.72M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $60.84M | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $750.21M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $702.06M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $630.86M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $502.15M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $509.00M | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $113.05M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $124.64M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $90.36M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $110.66M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $119.52M | Mar 1, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $967.15M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $913.06M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $938.39M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $865.72M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $789.85M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $794.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $693.87M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $689.46M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $652.97M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $812.86M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $615.42M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $490.81M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $443.67M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $694.28M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $584.31M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $427.89M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $339.51M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $359.08M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $345.77M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.20M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $82.77M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $55.42M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $50.61M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $53.34M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $70.17M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $74.93M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $84.98M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $57.23M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $81.93M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.84B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.99B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.81B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $4.59B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $4.98B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $4.87B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $4.45B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $3.53B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $3.45B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.89B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.29B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.60B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.56B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.76B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.08B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.04B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $2.77B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.13B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $2.02B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.59B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.55B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.25B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $1.83B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $1.90B | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $1.83B | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $1.69B | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $1.40B | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $1.42B | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $1.29B | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.78B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.68B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.68B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.73B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.70B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.57B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $1.39B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.34B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $1.07B | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.24B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.09B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $780.01M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $732.47M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $741.66M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $648.66M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $438.45M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $355.98M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $358.12M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $853.84M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $648.25M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $583.67M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $646.77M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $899.46M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $680.44M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $467.10M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $368.40M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $504.47M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $422.62M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.22B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.26B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.28B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.66B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.34B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.37B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.01B | Mar 2, 2020 |
| FY2016 | Dec 31, 2016 | $737.33M | Mar 1, 2017 |
| FY2016 | Dec 31, 2015 | $776.47M | Mar 1, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 170.34M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 174.66M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 179.49M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 182.92M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 185.34M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 189.05M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 190.12M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 189.35M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 192.83M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 198.79M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $117.75M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $108.47M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $100.01M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $91.84M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $80.48M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $74.21M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $64.67M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $57.10M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $46.69M | Mar 2, 2020 |